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IntroductionThe Peptide Nucleic Acids (PNAs) are synthetic organic polymer similar to DNA and RNA, with differences in structure composition [1,2]. While DNA and RNA have a skeleton formed by the sugars deoxyribose and ribose respectively, PNA is composed of repeating units of N-(2-aminoethyl)-glycine, joined by peptide bonds. The purine and pyrimidine bases are linked to the skeleton via methylene carbonyls linkages [3]. PNA does not contain phosphate groups, so the PNA/DNA is stronger than DNA/DNA duplex, due to reduced electrostatic repulsion. 
The high affinity of PNA to bind DNA and RNA allows the use of very short PNA oligomers (13-20bp). PNA oligomers also 
show greater specificity and are stable over a wide pH range. Furthermore, their electrically neutral nature may facilitate passage through the cell membrane, increasing the therapeutic value [3]. PNA shows preferably a helical conformation called “P-form”, different from any other stranded nucleic acids [4]. The structural characteristics of the PNA make it suitable for 
further chemical modifications, such as the replacement of units of glycine with any other amino acid.PNAs were originally created for DNA binding, in order to study the mechanism of double helix invasion. Subsequently, they have been applied in microbiology, virology and pharmacology and recently in genetics and cytogenetics. PNAs have important chemical-physical properties exploited for the development of biomolecular tools, such as molecular probes, biosensors and antisense agents [1].
In recent years, PNAs have emerged for many applications in cancer diagnosis and experimental therapy due to their peculiar characteristics. In this opinion, we summarized the recent progresses in leukemia diagnosis using PNA biotechnology.
PNA-FISHThe use of PNA probes in Fluorescence In Situ Hybridization (FISH) analysis is one of the most interesting applications [5]. PNAs are compatible with a wide range of molecules reporters 
and fluorochromes [3]. The physical properties of PNAs endow 
them with specific advantages over standard oligonucleotides probes: low intensity of background signal and high stability [6]. Initially, the technique of the PNA-FISH has been used for the quantitative analysis of telomeres [5,7]. The discriminatory 
characteristic of PNAs can also increase the identification of chromosomal variations and analysis of polymorphisms, 
through the synthesis of allele-specific PNA [8]. Furthermore, these unique features have been exploited to design assays able to highlight single base mutations at single cell level (e.g. Bcr-Abl T315I, JAK2 V617F), undetectable with traditional FISH test [9-11].
PNA mediated PCR clampingAnother application of PNA probe concerns the PCR. PNA/DNA chimeras cannot be recognized by DNA polymerase, suppressing the PCR reaction. This strategy, called PNA-mediated 
PCR clamping, uses PNA probes to inhibit the amplification of 
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a specific target sequence. The direct competition between 
PNA probe and conventional primer allows the amplification of interesting sequence. The lower charge repulsion between PNA and DNA favours the melting temperature (Tm) to remain independent from the concentration of salts [3]. Therefore, this procedure can be used to identify genetic variants [12], single base mutation [11] or mutations involving wider genomic regions (e.g. deletions and insertions) [13]. Although DNA sequencing is the most common diagnostic method and allows to analyze the entire sequence of interest, this PNA based assay 
resulted to be more sensitive, specific and cheaper.
PNA mediated real time PCR clampingMethod based on PNA Real Time PCR (RT-PCR) Clamping 
allows the quantification of specific mutations or variants at known positions. The PNA probe is designed to bind the wild type 
[14] sequence of the gene of interest, inhibiting its amplification. PNA can compete with either a TaqMan probe [15,16] or with a DNA primer when using Sybr Green as a DNA intercalates 
[17]. This direct competition allows the amplification and 
quantification of interesting sequence (e.g. DNMT3A R882H). Considering the high cost and the relatively low sensitivity of the DNA sequencing method, the PNA RT-PCR assay results faster and more sensitive in detecting and monitoring low level mutations in clinical samples.
PNA mediated droplet digital PCRThe Droplet digital PCR (ddPCR) is one of the most sensitive method for measuring target nucleic acid sequence quantity, it is useful for determining somatic mutation rates using TaqMan probes. By combination of PCR with PNA and ddPCR (PNA–ddPCR), it may be possible to successfully detect low prevalent mutant alleles more sensitively than with ddPCR alone [18]. Furthermore, the use of PNAs in ddPCR allows to improve also 
the specificity of the usual ddPCR [19].
PNA target in vitro and in vivoThe use of normal and thioate antisense oligonucleotides in vitro and in vivo displayed a number of limits: nuclease 
degradation, insufficient target affinity and non-specific effects. 
By contrast, the PNAs stability in biological fluids and their high 
affinity hybridization characteristics suggest that PNAs could be used as antisense agents in vitro and in vivo.  If PNAs were conjugated with Nuclear Localisation Signal peptide (NLS), they can cross cell membrane and interfere with the stability of target mRNAs and proteins translation [20]. Similar results were obtained with in vivo injection in rat brain [21]. Further study showed that PNAs are also able to cross the blood-brain barrier [22].
These findings suggest that antisense PNAs could be 
considered a new strategy for targeting of cell-specific anti-gene therapy in cancer.
ConclusionPNAs provide a novel class of organic polymer with wide biological potential as tools for diagnostic applications and therapeutic compounds. Their versatility, stability and easily to use, features widely discussed above, make them an excellent alternative to the most common methods, such as FISH and DNA sequencing. Their heir peculiar characteristics allow their use also in the most advanced techniques (ddPCR), improving 
in sensitivity and specificity. Furthermore, their potential use in vivo makes them excellent candidates for gene therapies, increasingly attractive in translational research.
References
1. Pellestor F, Paulasova P, Macek M, Hamamah S (2004) The peptide nucleic acids: a new way for chromosomal investigation on isolated cells? Hum Reprod 19(9): 1946-1951.
2. Wittung P, Nielsen PE, Buchardt O, Egholm M, Norden B (1994) DNA-like double helix formed by peptide nucleic acid. Nature 368(6471): 561-563.
3. Nielsen PE, Egholm M (1999) An introduction to peptide nucleic acid. Curr Issues Mol Biol 1(1-2): 89-104.
4. Rasmussen H, Kastrup JS, Nielsen JN, Nielsen JM, Nielsen PE (1997) Crystal structure of a peptide nucleic acid (PNA) duplex at 1.7 A resolution. Nat struct biol 4(2): 98-101.
5. Pellestor F, Paulasova P, Macek M, Hamamah S (2005) The use of 
peptide nucleic acids for in situ identification of human chromosomes. J Histochem Cytochem 53(3): 395-400.
6. Williams B, Stender H and Coull JM (2002) PNA fluorescent in situ hybridization for rapid microbiology and cytogenetic analysis. Methods Mol Biol 208: 181-193.
7. Wick U, Kirsch M, Rauch A, Chudoba I, Lausen B, et al. (2005) FISH studies on the telomeric regions of the T-cell acute lymphoblastic leukemia cell line CCRF-CEM. Cytogenet Genome Res 111(1): 34-40.
8. Pellestor F, Paulasova P and Hamamah S (2008) Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis. Curr Pharm Des 14(24): 2439-2444.
9. Bracco E, Rosso V, Serra A, Carnuccio F, Gaidano V, et al. (2013) Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms. BMC cancer 13: 348.
10. Fontenete S, Barros J, Madureira P, Figueiredo C, Wengel J, et al. (2015) 
Mismatch discrimination in fluorescent in situ hybridization using different types of nucleic acids. Appl Microbiol biotechnol 99(9): 3961-3969.
11. Rosso V, Bracco E, Pedrola R, Carturan S, Signorino E, et al. (2015) Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH. Biomark Res 3: 15.
12. Petiti J, Rosso V, Lo Iacono M, Calabrese C, Signorino E, et al. (2018) 
Prognostic significance of The Wilms’ Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia. Leuk Res 67: 6-11.
13. Rosso V, Petiti J, Bracco E, Pedrola R, Carnuccio F, et.al. (2017) A novel assay to detect calreticulin mutations in myeloproliferative neoplasms. Oncotarget 8(4): 6399-6405.
14. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, et al. (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363(16): 1532-1543.
How to cite this article: Valentina Rosso, Jessica Petiti, Cristina Panuzzo, Daniela Cilloni. PNA: A Snapshot on their Applications in Leukemia Diagnosis 
and Research. Blood Res Transfus J. 2018; 2(1) : 555577. DOI: 10.19080/OABTJ.2018.02.555577003
Open Access Blood Research & Transfusion Journal
15. Kreuzer KA, Le Coutre P, Landt O, Na IK, Schwarz M, et al. (2003) Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique. Annals of hematology 82(5): 284-289.
16. Mancini M, Hasan SK, Ottone T, Lavorgna S, Ciardi C, et al. (2015) Two 
novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia. J Mol Diagn 17(2):179-184.
17. Jae-jin Choi MC, Miae Oh, Hyunsun Kim, Min-seock Kil, Heekyung Park (2010) PNA-mediated Real-Time PCR Clamping for Detection of EGFR Mutations. Bull Korean Chem Soc 31(12): 3525-3529.
18. Uchiyama Y, Nakashima M, Watanabe S, Miyajima M, Taguri M, et al. (2017) Corrigendum: Ultra-sensitive droplet digital PCR for detecting a low-prevalence somatic GNAQ mutation in Sturge-Weber syndrome. Sci Rep 7: 39897.
19. Zhu G, Ye X, Dong Z, Lu YC, Sun Y, et al. (2015) Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in 
Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer. J Mol Diagn 17(3): 265-272.
20. Rapozzi V, Burm BE, Cogoi S, van der Marel GA, van Boom JH, et al. (2002) Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids. Nucleic Acids Res 30(17): 3712-3721.
21. Aldrian-Herrada G, Desarmenien MG, Orcel H, Boissin-Agasse L, Mery J, et al. (1998) A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res 26(21): 4910-4916.
22. Tyler BM, Jansen K, McCormick DJ, Douglas CL, Boules M, et al. (1999) Peptide nucleic acids targeted to the neurotensin receptor and 
administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc Natl Acad Sci USA 96(12):7053-7058.
Your next submission with Juniper Publishers    
      will reach you the below assets• Quality Editorial service• Swift Peer Review• Reprints availability• E-prints Service• Manuscript Podcast for convenient understanding• Global attainment for your research• Manuscript accessibility in different formats          ( Pdf, E-pub, Full Text, Audio) • Unceasing customer service                     Track the below URL for one-step submission 
               https://juniperpublishers.com/online-submission.php
This work is licensed under Creative
Commons Attribution 4.0 License
DOI: 10.19080/OABTJ.2018.02.555577
